Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib.
For patients with established cardiovascular disease,aspirin is clearly beneficial as part of secondary prevention. However, when used as primary prevention in patients without documented cardiovascular disease, its benefit is much less certain. This podcast will explore 3 recent trials that evaluated aspirin in different populations and found nobenefit for its use as primary prevention.
Join us as we discuss a recent study of push-up capacity in middle-aged men and the association with CVD risk.
In this episode we expand on the rationale for not screening and treating hyperlipidemia in patients without CV disease, diabetes, renal failure or heart failure.
Managing cholesterol is one of the most common clinical problems. Recently, the American College of Cardiology and the American Heart Association issued new guidance on the management of blood cholesterol. Ten other societies participated in the development of the guidelines. Listen to find out who should be treated with statins, what the treatment targets are, and when other cholesterol-lowering medications should be added.
In a recent study, data from the Cardiovascular Health Study examined the association between alcohol consumption and incident HF. It was found that moderate alcohol consumption was associated with a survival benefit, implying that individuals 65 years and older with newly diagnosed HF may not need to stop their alcohol use. Join the discussion about these findings and learn how they may impact the care of your patients with HF.
Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes.
Recurrent pericarditis is a serious complication of pericarditis, and clinical recognition from healthcare providers is essential to improve outcomes and reduce the burden of disease. However, non-specific symptoms such as chest pain and dyspnea can make it a challenge to diagnose. In this practical session, you will review guidelines for diagnosing pericarditis as well as features that distinguish it from other diseases. Expert insights will refresh your knowledge of the treatment toolbox and illustrate the options on the horizon with the potential to expand it.
This talk will discuss the appropriate use of PPIs, including FDA indications and other accepted uses based on guidelines and systematic reviews. There will also be a brief review of the literature regarding issues of PPI safety. While many retrospective studies have raised concerns about various health conditions associated with PPI use, the quality of these studies need to be accounted for when considering the potential benefit that can be derived from these medications, even with long-term use. Finally, the faculty will provide a summary of “best practices."
In this session, you will receive the most important cardiology updates from 2018-2019, including trial evidence for dietary supplements in the prevention of cardiovascular disease and new information about the blood cholesterol guidelines. The session will also provide advice on how to differentiate between opportunistic and systematic screening for atrial fibrillation as well as identify ways to conduct this screening in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th 2020 and they are subject to change as new information is published.
In the last 3 decades, our improved knowledge of heart failure etiology has been the catalyst for major advances in its medical management. This session will help you to understand the modern pharmacologic treatment of patients with this syndrome and offer a peek into advances that can be expected in the coming years. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 2/8/2020, and they are subject to change as new information is published.
In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th, 2020, and they are subject to change as new information is published.